SequelSEC

NEPHROS INC NEPH

Surgical & Medical Instruments & Apparatus · CIK 0001196298 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$20.72M
Fiscal year ended 2026-06-30
Operating income
$1.64M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$27.32MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$2.57Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / net income22.9×A lower bound on the multiple, because affiliate holdings are excluded.
Float / revenue1.5×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity2.7×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
SBC / revenue1.6%18th
Effective tax rate1.0%21th
Net margin6.4%79th
Revenue YoY growth32.7%77th
Operating margin6.1%74th
R&D / revenue7.1%33th
Current ratio4.06x62th
Gross margin61.9%50th

NEPHROS INC (NEPH) reported revenue of $20.72M and net income of $1.74M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from NEPHROS INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

NEPHROS INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$20.72M
Cost of revenue$8.03M
Gross profit$12.70M
Operating income$1.64M
Net income$1.74M
Research & development$1.44M
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expense$16.00K
Diluted EPSUnavailable
Selling, general & administrative$9.48M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

NEPHROS INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$4.70M
Total assets$15.77M
Current assets$13.60M
Total liabilities$3.80M
Current liabilities$3.34M
Total equity incl. NCI$11.97M
Temporary (mezzanine) equityUnavailable
Inventory$4.55M
Accounts receivable$4.10M
Goodwill$759.00K
Long-term debtUnavailable
Accounts payable$1.96M

Cash flow

NEPHROS INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$706.00K
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$284.00K
Net change in cash-$377.00K
Stock-based compensation$270.00K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$124.00K

Derived

NEPHROS INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin61.3%
Operating margin7.9%
FCF marginUnavailable
SBC / revenue1.3%
Current ratio4.07x
Revenue YoY growth24.2%
Net margin8.4%
R&D / revenue7.0%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open NEPH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-10View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-03-12View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.